TRIM21 and interstitial lung disease: Additionally, a study evaluating patients with anti-MDA5 antibody-positive, non-myopathic dermatomyositis complicated by pulmonary interstitial disease found that anti-RO-52 antibodies were significantly associated with rapidly progressive ILD and the development of skin ulcers.